Acute renal artery thrombosis associated with factor V Leiden mutation

Nephrology Dialysis Transplantation

Volumn 11, Issue 10, 1996, Pages 2067-2069

  Le Moine, A ^a   Chauveau, D ^a   Grunfeld J P ^a  

^a HÔPITAL NECKER ENFANTS MALADES   (France)

Author keywords

Factor V Leiden mutation; Oral contraceptives; Renal artery thrombosis

Indexed keywords

ANTICOAGULANT AGENT; BLOOD CLOTTING FACTOR 5; COUMARIN ANTICOAGULANT;

ADULT; ARTICLE; CASE REPORT; COMPUTER ASSISTED TOMOGRAPHY; FEMALE; GENE MUTATION; HUMAN; KIDNEY ARTERIOGRAPHY; KIDNEY INFARCTION; PRIORITY JOURNAL; RENAL ARTERY THROMBOSIS;

EID: 0029956693     PISSN: 09310509     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.ndt.a027099     Document Type: Article

References (11)

1. Stadel B. Oral contraceptives and cardiovascular disease (second of two parts). N Engl J Med 1981; 305: 672-677
2. Radwanska E. The role of reproductive hormones in vascular disease and hypertension. Steroids 1993; 58: 605-610
3. Lidegaard O. Oral contraception and risk of a cerebral thromboembolic attack: results of a case control study. BMJ 1993; 306: 956-953
4. Weiss N. Third-generation oral contraceptives: how risky? Lancet 1995: 346: 1570
5. Jick H, Jick SS, Gurewich V, Myers MW, Vasilakis C. Risk of idiopathic cardiovascular death and non-fatal venous thromboembolism in women using oral contraceptives with differing progestagen components. Lancet 1995; 346: 1589-1593
6. Fiorini E, Fioretti M, Moscatelli A, Bartolucci L, Valori C. Osservazioni su un caso di ipertensione arteriosa, associata ad iperparathyroidismo primario ed a trombosi di arteria renale. Minerva Cardioangiol 1993; 41: 405-408
7. Svensson PJ, Dahlback B. Resistance to activated protein C as a basis for venous thrombosis. N Engl J Med 1994; 330: 517-522
8. Vandenbroucke J, Koster T, Briët E, Reitsma P, Bertina R, Rosendaal F. Increased risk of venous thrombosis in oralcontraceptives users who are carriers of factor V Leiden mutation. Lancet 1994; 344: 1453-1457
9. Simoni P, de Ronde H, Prandoni P, Saladini M, Bertina R, Girolami A. Ischemic stroke in young patients with activated protein C resistance. Stroke 1995; 26: 885-890
10. Ridker P, Hennekens C, Lindplaitner K, Stampfer M, Eisenberg P, Miletich J. Mutation in the gene coding for cagulation factor V and the risk of myocardial infarction, stroke, and venous thrombosis in apparently healthy men. N Engl J Med 1995; 332: 912-917
11. Bloemenkamp K, Rosendaal F, Helmerhorst F, Büller H, Vandenbroucke J. Enhancement by factor V Leiden mutation of risk of deep-vein thrombosis associated with oral contraceptives containing a third-generation progestagen. Lancet 1995; 346: 1593-1596